Figure 5.
Locations of the amino acids whose substitutions led to different Kell polymorphisms. The amino acids whose mutations led to different Kell phenotypes are labeled (green) and are shown on a backbone structure of a model of the Kell ectodomain. The active and substrate binding sites are marked by the locations of zinc (pink ball) and of the inhibitor, phosphoramidon (yellow).